| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Issues Articles
Insulin resistance specifically in the brain is being proposed as the reason for the memory loss that characterizes Alzheimer's disease. Because Alzheimer's may be caused by insulin-related dysfunction, some scientists are calling Alzheimer's by a new name: type 3 diabetes.
Insulin, according to previous research, is produced in the brain as well as in the pancreas. During early Alzheimer's, the brain's insulin levels and the quantity of its insulin receptors fall quickly, and they continue to drop progressively as the disease advances. In its most advanced stage, an Alzheimer brain has nearly eighty percent fewer insulin receptors than a normal brain. Thus, insulin resistance in the brain is associated with Alzheimer's disease.
Until now, exactly why the insulin receptors disappear has not been known. But now researchers from Northwestern University think they have it figured out.
First, here's a short lesson on how neurons (brain cells) communicate. Neurons have three parts: tree-shaped dendrites, a cell body, and a long axon. To get from one neuron to the next, information from the first neuron flows from its cell body, down its axon, then across a little space called a synapse, to the dendrites of the next neuron. When all is working well, insulin binds to insulin receptors on the dendrites at a neuron's synapse, turning on a mechanism necessary for nerve cells to survive and memories to form.
But now researchers have found that a toxic protein in the brains of Alzheimer's patients prevents insulin receptors from setting up for business at the neuronal dendrites. The toxic proteins, called ADDLs (short for "amyloid beta-derived diffusible ligands"), are small proteins that accumulate at the beginning of Alzheimer's disease. ADDLs bind to the neuron dendrites, hogging the spots and preventing insulin receptors from gathering there.
As a result, the insulin receptors pile up in the cell bodies where the insulin can't get to them. Because the bound ADDLs prevent the insulin receptors from getting near the synapses, there is a rapid loss of insulin receptors from the dendritic surfaces of the neurons. This is why nerve cells become insulin resistant in Alzheimer's.
The researchers found that neurons that had ADDLs bound to them had no insulin receptors on their dendrites. Conversely, the dendrites with lots of insulin receptors had no bound ADDLs. They think that ADDLs, because they block the insulin receptors from reaching the synapses, are a major factor in the memory deficits in Alzheimer's patients. In fact, they believe that insulin resistance in the Alzheimer brain is a response to ADDLs, which, by disrupting insulin signaling, are causing a brain-specific form of diabetes.
Sources: The FASEB Journal; BBC News; Diabetes in Control; Science Daily, September 2007
Categories: Professional Issues, Type 2 Issues
Nov 27, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.